Overview Fundamentals API Earnings EOD API Sample Code Pricing

Spero Therapeutics Inc (SPRO NASDAQ) stock market data APIs

$1.32 0.01(0.8%) as of September 6, 2024
Price chart is built with Anychart

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, an intravenous-administered antibiotic against MDR Gram-negative pathogens comprising carbapenem-resistant enterobacterales (CRE), acinetobacter baumannii, and pseudomonas aeruginosa, as well as negative bacterial infections in the hospital setting; and SPR720, a novel oral antibiotic agent for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Spero Therapeutics Inc Financial Data Overview

1.315
1.32
-
1.33
1.28
0.99-1.89
71 075 K
3.8676
54 049 K
118 M
-0.33
0.624
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SPRO',
Type: 'Common Stock',
Name: 'Spero Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00HXSJ1R2',
ISIN: NULL,
CUSIP: NULL,
CIK: '1701108',
EmployerIdNumber: '46-4590683',
FiscalYearEnd: 'December',
IPODate: '2017-11-02',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Spero Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 118 M
  • EBITDA 21 008 K
  • Earnings Per Share 0.34
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Spero Therapeutics Inc Earnings via APIs

  • Latest Release 2024-08-05
  • EPS/Forecast -0.38

Get Spero Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com